Rare Disease Treatments Poised for Robust Growth, Reaching $12B by 2027
• Global rare neurological disease treatment market expected to reach $12.36 billion by 2027, growing at a CAGR of 8.3%
• Orphan drugs gaining popularity as targeted therapies for rare diseases
• North America dominates the market, but Asia-Pacific is the fastest growing region
• Mergers and acquisitions shaping the market landscape as companies aim to expand product portfolios
• Market driven by alarming prevalence rates of rare neurological disorders and demand for novel treatments